Oxy­tocin ban de­ci­sion

The Hindu Business Line - - PULSE -

A de­vel­op­ment is ex­pected soon on the pro­posed ban on pri­vate pro­duc­tion of Oxy­tocin, used to pre­vent ex­ces­sive bleed­ing dur­ing child­birth. Due to ap­par­ent mis­use of the drug, the Health Min­istry sought to ban pri­vate pro­duc­ers from mak­ing and mar­ket­ing it in the coun­try. To meet lo­cal sup­plies, the Cen­tre ap­pointed Karnataka An­tibi­otics & Phar­ma­ceu­ti­cals Ltd. But as doc­tors cau­tioned that the move could af­fect hos­pi­tal sup­plies, the pri­vate ban was de­ferred. Sub­se­quently, pri­vate pro­duc­ers ap­proached the Delhi High Court. Presently, the HC stay on the pri­vate ban stands up to De­cem­ber 15. Doc­tors, pri­vate pro­duc­ers of the drug and gov­ern­ment are keenly watch­ing what hap­pens next.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.